Atlas Japan GK

History

2022: Atlas entered the Japanese market

In mid-February 2022, it became known that the Russian biomedical holding Atlas had created a company in Japan to sell its genetic tests and microbiota tests there to study the bacterial composition of the intestinal environment. As the founder and CEO of the holding Sergey Musienko told Vedomosti, the Japanese subsidiary - Atlas Japan GK - was registered in 2021, at the same time the office of the new company was launched.

According to Musienko, investments in the launch of business in Japan amounted to about $0.5 billion, these were the company's own funds. The money went to register a legal entity in the country, hiring personnel, building operational processes and marketing.

Russian genetic test developer Atlas enters the Japanese market

The head of Atlas, speaking about the reasons for entering the Japanese market, noted that it is growing rapidly, and local authorities and insurance companies are encouraging a trend towards preventive medicine and an extension of the period of active longevity in the population. In Japan, there is even a system of bonuses for the client to complete a certain number of steps and cashback if, according to the results of the medical examination, a person's body mass index has improved. Lifestyle-related diseases account for about 30% of national medical costs and about 50% of deaths, according to data from the Japanese Association for the Prevention of Lifestyle Diseases, which the publication refers to.

According to analysts of Mordor Intelligence, the volume of the global market for microbiome therapy and diagnostics (microbiome - a community of microorganisms that inhabit a certain environment) of humans in 2021 reached $559 million.

By February 2022, Atlas offers genetic tests for 13,400 rubles indicating the risks of diseases and helping to learn about their origin and find relatives.^[1]

Notes